Characterization of a Novel Oral Small Molecule PTH1R Agonist: Proof of Concept for an Alternative to Injectable Peptide-based Therapy for Hypoparathyroidism - Septerna

06.03.24

Publication

Up Next

View All

Septerna to Present at Bank of America Securities Health Care Conference

No results found.